standard of care in braf v600e mnsclc
Published 4 years ago • 49 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
7:40
treatment options for braf v600e mnsclc
-
3:53
targeted therapies for braf v600e-mutated mnsclc
-
5:44
braf/mek combination in braf v600e disease - 2022 program: targeted therapies forum
-
5:35
gracecast - what is the optimal treatment for patients with advanced nsclc and a braf-v600e mutation
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
2:56
treating braf v600e-mutant nsclc with dabrafenib and trametinib
-
10:08
impact of braf-v600e mutation on the tumour microenvironment and associated genomic alterations ...
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
26:14
how to treat non-small cell lung cancer with actionable mutations with dr. balazs halmos
-
2:53
highlights: testing to treatment of braf-mutant metastatic nsclc
-
1:55
dr. lieu on the predictive value of braf v600e mutations in crc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
9:16
changing treatment paradigm for braf-mutant nsclc
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
5:16
treatment of braf-mutant nsclc
-
4:08
what is your recommended first-line treatment option for braf mutated nsclc?
-
1:42
progress made in treating braf v600e metastatic nsclc
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
1:18
how braf v600e-mutated crc is treated differently than other cancers
-
2:45
ulixertinib in tumors with braf fusions, non-v600e or non-v600k braf mutations
-
2:02
braf v600e as a target in advanced non small cell lung cancer